293:HKEXCathay Pacific Airways Limited Analysis
Data as of 2026-05-21 - not real-time
¥1,465.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Okamura Foods is trading at ¥1,465, essentially at its 52‑week high of ¥1,469, with the 20‑day SMA (¥1,248.8) comfortably below the current price and a bullish MACD histogram (+¥23.8) confirming upward momentum. However, the RSI of 80.4 signals that the stock is deeply overbought and may face short‑term pressure near the resistance level of ¥1,469. Volume is increasing, supporting the recent rally but also amplifying the risk of a pull‑back.
Fundamentally, the company posted a 20.6% revenue surge and maintains a modest gross margin of ~22%, yet it is burdened by an extreme debt‑to‑equity ratio of 183, zero operating cash flow and free cash flow, and a low dividend yield of 0.55% with a modest payout ratio. The valuation metrics (PE ~30, PB ~3.9) appear stretched given the cash‑flow constraints, while volatility is high at 36% and the Fear & Greed Index reflects “Extreme Greed,” suggesting heightened market euphoria.
Fundamentally, the company posted a 20.6% revenue surge and maintains a modest gross margin of ~22%, yet it is burdened by an extreme debt‑to‑equity ratio of 183, zero operating cash flow and free cash flow, and a low dividend yield of 0.55% with a modest payout ratio. The valuation metrics (PE ~30, PB ~3.9) appear stretched given the cash‑flow constraints, while volatility is high at 36% and the Fear & Greed Index reflects “Extreme Greed,” suggesting heightened market euphoria.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD but overbought RSI
- Price near resistance at ¥1,469
- Rising volume supporting short‑term momentum
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth of 20% YoY
- High debt load and zero cash flow
- Elevated valuation multiples (PE ~30, PB ~3.9)
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Unsustainable leverage (Debt/Equity > 180)
- Lack of operating and free cash flow
- Low dividend yield and modest payout ratio
Key Metrics & Analysis
Financial Health
Revenue Growth20.60%
Profit Margin6.57%
P/E Ratio30.2
ROE14.63%
ROA4.27%
Debt/Equity183.49
P/B Ratio3.9
Technical Analysis
TrendBullish
RSI80.4
Support¥1,171.00
Resistance¥1,469.00
MA 20¥1,248.80
MA 50¥1,219.30
MA 200¥1,187.14
MACDBullish
VolumeIncreasing
Fear & Greed Index91.5
Valuation
GradeOvervalued
TypeGrowth
Dividend Yield0.55%
Risk Assessment
Beta-0.30
Volatility36.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.